<DOC>
	<DOCNO>NCT00389259</DOCNO>
	<brief_summary>Organophosphate ( OP ) compound major threat chemical warfare agent terrorist act . OPs also active ingredient many insecticide . Ingestion insecticides common cause death among people commit suicide develop country . OPs poison also frequently occur accidental exposure agricultural OPs child result unintentional ingestion . The use competitive inhibitor acetylcholine atropine patient organophosphate ( OP ) poison controversial . Because scopolamine ' ability cross blood brain barrier well atropine , suggest scopolamine use OP poison patient central nervous system ( CNS ) manifestation . However controversy regard potential benefit treatment organophosphate poisoning human . To best knowledge randomise controlled study use scopolamine human . This prospective randomise control study aim determine whether add scopolamine standard treatment atropine oximes patient CNS symptom OP poison improve outcome .</brief_summary>
	<brief_title>Scopolamine Treatment Patients With Organophosphate Poisoning</brief_title>
	<detailed_description>Objective : determine whether add scopolamine standard treatment atropine oxime improve outcome patient OP poison CNS manifestation . Design : A multi-center , randomize , double blind , placebo control study . Setting : Emergency Departments &amp; Intensive Care Units Israel . Participants : Patients 2 -60 year old acute OP poison CNS manifestation . Interventions : In addition standard treatment atropine obidoxime , eligible patient randomly assign one two treatment group , scopolamine group , placebo group ( give volume ) . Scopolamine give IM IV dose 0.25mg adult 0.006mg/kg child every 4 hour . At least three dos scopolamine ( placebo ) give . The medical staff blind treatment give . Main outcome measure : Improvement neurological status , duration seizure number day ventilator . Data analysis : The main outcome measure , compare use Student 's t-test Mann-Whitney test appropriate . The *2 Fisher Exact test , appropriate , use comparison categorical variable . We use multiple logistic regression examine extent variable predict success failure treatment .</detailed_description>
	<mesh_term>Neurotoxicity Syndromes</mesh_term>
	<mesh_term>Poisoning</mesh_term>
	<mesh_term>Organophosphate Poisoning</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<criteria>Age : 2 60 year At least two follow three criterion : Known exposure organophosphate carbamate insecticide last 72 hour . Symptoms sign typical organophosphate poison involve least two system ( gastrointestinal , respiratory , skin , eye , ) See appendix Low level plasma butyrylcholinesterase ( le 50 % low normal range ) CNS involvement first 72 hour exposure : determined find least one follow major criterion least two minor criterion Major criterion CNS involvement : Seizures Extrapyramidal Parkinson like symptom Decreased level consciousness ( GCS &lt; 12 ) Minor criterion CNS involvement : GCS 1412 Confusion Hallucinations Hypersensitivity scopolamine Glaucoma , narrowangle ( angleclosure ) Tachyarrhythmias , congestive heart failure Obstructive gastrointestinal disease Myasthenia Gravis Reflux esophagitis Ulcerative colitis Known obstructive uropathy Pregnancy Patient legal guardian unable give inform consent ( see comment ethic ) Severe comorbidity ( multitrauma , advanced cancer , etc )</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Insecticides</keyword>
	<keyword>Organophosphate</keyword>
	<keyword>Scopolamine</keyword>
	<keyword>randomize control study</keyword>
	<keyword>Organophosphate carbamate intoxication</keyword>
</DOC>